IGF1 and breast carcinoma: Prospective studies consistently indicate that greater height is associated with an increased risk of prostate (aggressive forms), colorectal and breast cancer,13, 38 and it is possible that increased IGF‐I bioavailability, which may be influenced by IGFBP‐1,32, 33 may account for part of these associations.